Hepatitis B Virus Reactivation under Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia

Turk J Haematol. 2020 Aug 28;37(3):208-209. doi: 10.4274/tjh.galenos.2020.2019.0180. Epub 2020 Apr 6.

Authors

Gülşen İskender¹, Dicle İskender², Mustafa Ertek¹

Affiliations

¹ Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Ankara, Turkey
² Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Clinic of Hematology and Blood and Marrow Transplantation, Ankara, Turkey

No abstract available

Keywords: Hepatitis B reactivation; Ibrutinib; Chronic lymphocytic leukemia.

Publication types

Case Reports

MeSH terms

Adenine / adverse effects
Adenine / analogs & derivatives*
Adenine / therapeutic use
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use*
Hepatitis B Core Antigens / immunology
Hepatitis B virus / immunology*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
Leukemia, Lymphocytic, Chronic, B-Cell / immunology
Male
Middle Aged
Piperidines / adverse effects
Piperidines / therapeutic use*
Protein Kinase Inhibitors / adverse effects
Protein Kinase Inhibitors / therapeutic use*
Virus Activation / drug effects
Virus Activation / immunology

Substances

Antineoplastic Agents
Hepatitis B Core Antigens
Piperidines
Protein Kinase Inhibitors
ibrutinib
Adenine